Latest Articles

Publication Date
ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide - ACCESS Newswire

ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide ACCESS Newswire

Published: March 19, 2025, 12:02 p.m.
NHS approval of endometriosis therapy Ryeqo enhances patient care - The Hippocratic Post

NHS approval of endometriosis therapy Ryeqo enhances patient care The Hippocratic Post

Published: March 19, 2025, 12:01 p.m.
ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide - Newswire

ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide Newswire

Published: March 19, 2025, noon
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Canada Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Canada …

Published: March 19, 2025, 11 a.m.
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Finance

Published: March 19, 2025, 11 a.m.
Analysis of risk factors for recurrence after laparoscopic myomectomy: A retrospective study.

At present, there is unclear on the risk factors of recurrence after myomectomy. In this study, we hope to provide reference for the choice of treatment for patients with uterine …

Published: March 19, 2025, 12:17 a.m.
Assessing healthcare needs in endometriosis: a scoping review.

Women with endometriosis still have to seek the legitimacy of their disease from the medical community and often feel unheard. This scoping review aims to map the scientific literature to …

Published: March 19, 2025, midnight
Ireland's healthcare system doesn't listen to endometriosis patients - Irish Examiner

Ireland's healthcare system doesn't listen to endometriosis patients Irish Examiner

Published: March 18, 2025, 12:54 a.m.
Using electronic health record data to identify incident uterine fibroids and endometriosis within a large, urban academic medical center: a validation study.

Electronic health records (EHRs) present opportunities to study uterine fibroids uterine fibroids and endometriosis within diverse populations. When using EHR data, it is important to validate outcome classification via diagnosis …

Published: March 18, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!